T細胞免疫療法では,中性粒子が腫瘍抗原脱出変異体を排除する
Daniel Hirschhorn1, Sadna Budhu1, Lukas Kraehenbuehl2
1Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, NY, USA.
Cell
|March 31, 2023
まとめ
腫瘍が抗原を失うと 免疫療法は失敗するかもしれません CD4+ T細胞療法と免疫チェックポイントの阻害を組み合わせると,中性粒子を誘導することで,抗原損失メラノーマを効果的に根絶します.
科学分野:
- 免疫学
- 腫瘍学
- 癌 研究
背景:
- アドプティブT細胞移植および他のがん免疫療法は,腫瘍の進化と抗原喪失変異により課題に直面しています.
- 腫瘍脱出変種は免疫反応を回避し,標的治療の有効性を制限する.
研究 の 目的:
- CD4+ T細胞療法と免疫チェックポイント阻害 (OX40共刺激またはCTLA-4阻害) を併用することで,メラノーマにおける抗原損失を克服できるかどうかを調査する.
- 抗原脱出変異の根絶に関与する中性粒子の役割を含む免疫メカニズムを解明する.
主な方法:
- CD4+ T細胞療法とOX40共刺激またはCTLA-4阻害を併用したマウスのメラノーマモデルを使用した.
- 腫瘍における免疫細胞集団と活性化状態を評価するために,トランスクリプトミカルとフロー・サイトメトリー分析を使用した.
- 中性粒子の役割と誘導性酸化窒素合成酵素 (iNOS) の腫瘍根絶を調査した.
主要な成果:
- 抗原脱出変異を含むメラノーマは,最初のT細胞認識を必要とする.
- 腫瘍の完全な根絶は中性粒子を依存し,ある程度は誘導可能な酸化窒素合成酵素に依存した.
- 免疫チェックポイント阻害療法による治療を受けたマウス腫瘍およびヒトメラノーマ患者の生検で,中性粒子の有意な活性化が観察されました.
結論:
- CD4+T細胞療法と免疫チェックポイントブロックは,メラノーマにおける抗原喪失変異体を排除することができます.
- 中性粒子は,T細胞反応とともに,腫瘍抗原喪失変異体の破壊を媒介する上で重要な役割を果たします.
- 発見は,腫瘍の免疫回避戦略を克服する際に,T細胞と中性粒子の相乗効果の相互作用を明らかにしています.
さらに関連する動画
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
377
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
898
関連する概念動画
01:27Tumor Immunotherapy
598
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
598
01:27Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
01:28Cells of the Innate Immune Response
1.8K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.8K
01:22T Cell Activation and Clonal Selection
1.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
1.1K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K